SCHEMBL12716610

SCHEMBL12716610

CC(C)(C)c1cc2ccc3ccc(-c4ccc5c6ccc(-c7cccc8ccccc78)cc6n(-c6ccccc6)c5c4)c4ccc(c1)c2c34

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPK1 P28482 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
NTSR1 P30989 2/20 0.36
ERBB2 P04626 1/20 0.35
CYP1A2 P05177 1/20 0.35
FYN P06241 1/20 0.35
MAOA P21397 1/20 0.35
ACHE P22303 1/20 0.35
AHR P35869 1/20 0.35
PPARG P37231 5/20 0.35
PPARA Q07869 5/20 0.35
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
PPARD Q03181 1/20 0.34
MCL1 Q07820 1/20 0.34
ACMSD Q8TDX5 1/20 0.34
KDM4E B2RXH2 1/20 0.33
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12716586 0.95 ALDH1A1 (0.37) MAPTALDH1A1MAPK1NPSR1NTSR1
SCHEMBL12716580 0.94 ALDH1A1 (0.36) MAPTALDH1A1MAPK1NPSR1NTSR1
SCHEMBL12716581 0.93 ALDH1A1 (0.38) MAPTALDH1A1MAPK1NPSR1ERBB2
SCHEMBL12716539 0.92 KDM4E (0.41) MAPTALDH1A1MAPK1NPSR1ERBB2
SCHEMBL12716576 0.90 ALDH1A1 (0.35) MAPTALDH1A1MAPK1NPSR1ERBB2
SCHEMBL12716594 0.90 ALDH1A1 (0.36) MAPTALDH1A1MAPK1NPSR1KDM4E
SCHEMBL12716611 0.89 KDM4E (0.38) MAPTALDH1A1MAPK1NPSR1ERBB2
SCHEMBL12716568 0.88 CNR2 (0.37) MAPTALDH1A1MAPK1NPSR1RXRA
SCHEMBL12716592 0.87 ALDH1A1 (0.37) MAPTALDH1A1MAPK1NPSR1KDM4E
SCHEMBL12716640 0.85 ALDH1A1 (0.35) MAPTALDH1A1MAPK1NPSR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7923129-B2 extremely high efficiency and a high luminance and has an extremely high durability; 2-pyrenylcarbazoles; blue CANON KABUSHIKI KAISHA (JP) 2011-04-12 US disclosed
US-7923129-B2 extremely high efficiency and a high luminance and has an extremely high durability; 2-pyrenylcarbazoles; blue CANON KABUSHIKI KAISHA (JP) 2011-04-12 US disclosed
US-20080131731-A1 CARBAZOLE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CANON KABUSHIKI KAISHA (JP) 2008-06-05 US disclosed
US-20080131731-A1 CARBAZOLE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CANON KABUSHIKI KAISHA (JP) 2008-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080131731-A1 CARBAZOLE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME OXA1L, CYP2C19, PPOX MAPT 3175/4885ALDH1A1 30/4885MAPK1 1958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.